Taking into account the results from the experimental models which indicate a potential relevance of serum BMP8A levels for predicting the fibrosis stage, we measured circulating BMP8A levels in NASH patients with and without advanced hepatic fibrosis as well as in subjects with histologically normal liver (NL). This evidence concerns the gene BMP8A and metabolic dysfunction-associated steatohepatitis.